Protagonist Therapeutics (PTGX) Leases (2019 - 2025)
Protagonist Therapeutics' Leases history spans 7 years, with the latest figure at $7.8 million for Q4 2025.
- For Q4 2025, Leases fell 16.86% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, down 16.86%, while the annual FY2025 figure was $7.8 million, 16.86% down from the prior year.
- Leases for Q4 2025 was $7.8 million at Protagonist Therapeutics, down from $8.2 million in the prior quarter.
- Across five years, Leases topped out at $10.3 million in Q2 2024 and bottomed at $387000.0 in Q1 2024.
- The 5-year median for Leases is $4.6 million (2021), against an average of $5.2 million.
- The largest annual shift saw Leases crashed 84.86% in 2024 before it soared 2225.58% in 2025.
- A 5-year view of Leases shows it stood at $4.9 million in 2021, then tumbled by 37.99% to $3.1 million in 2022, then crashed by 68.83% to $954000.0 in 2023, then skyrocketed by 887.11% to $9.4 million in 2024, then fell by 16.86% to $7.8 million in 2025.
- Per Business Quant, the three most recent readings for PTGX's Leases are $7.8 million (Q4 2025), $8.2 million (Q3 2025), and $8.6 million (Q2 2025).